Research - , ,
MABLife is a private biotech company founded in 1999, specialising in the development of antibody-based therapeutics for the treatment of cancer, ophthalmic diseases, autoimmune & inflammatory disorders and nosocomial infections.The Company has a focused portfolio of products in development, including one product currently in phase I/II and four at different stages of preclinical development.